Pedro Chorão

1 month ago | nature.com | José Luis Piñana |Juan Montoro |Rafael Hernani |Pedro Chorão |Juan Carlos Hernandez-Boluda |David Navarro

Respiratory syncytial virus (RSV) poses a significant threat to allogeneic hematopoietic cell transplant (allo-HCT) recipients. Prolonged shedding in this population is common [1], increasing the risk of viral transmission and resistance [2], placing additional strain on healthcare systems. Despite the clinical importance of understanding illness duration in these patients, data remain limited [3].